CAG
AZN icon

Csenge Advisory Group’s AstraZeneca AZN Stock Holding History

Csenge Advisory Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Buy
2,853
+63
+2% +$11.8K 0.02% 442
2026
Q1 		$549K Sell
2,790
-179
-6% -$34.5K 0.03% 415
2025
Q4 		$546K Sell
2,969
-131
-4% -$23K 0.02% 419
2025
Q3 		$476K Buy
3,100
+465
+18% +$70.4K 0.02% 432
2025
Q2 		$384K Sell
2,635
-379
-13% -$53.1K 0.02% 491
2025
Q1 		$407K Buy
3,014
+1,457
+94% +$211K 0.02% 447
2024
Q4 		$204K Sell
1,557
-223
-13% -$31.2K 0.01% 664
2024
Q3 		$275K Buy
1,780
+283
+19% +$45.7K 0.01% 583
2024
Q2 		$234K Buy
+1,497
New +$225K 0.01% 586
2023
Q1 		– Sell
-2,360
Closed -$320K – 600
2022
Q4 		$320K Sell
2,360
-6
-0.3% -$752 0.02% 448
2022
Q3 		$260K Sell
2,366
-522
-18% -$66.2K 0.02% 502
2022
Q2 		$382K Sell
2,888
-1,733
-38% -$227K 0.03% 388
2022
Q1 		$613K Sell
4,621
-198
-4% -$23.7K 0.05% 329
2021
Q4 		$581K Sell
4,819
-1,845
-28% -$217K 0.05% 311
2021
Q3 		$795K Buy
6,664
+1,845
+38% +$215K 0.07% 266
2021
Q2 		$581K Buy
4,819
+2,504
+108% +$275K 0.05% 312
2021
Q1 		$231K Sell
2,315
-94
-4% -$9.45K 0.02% 446
2020
Q4 		$241K Buy
+2,409
New +$255K 0.03% 371
2018
Q4 		– Sell
-188
Closed -$15K – 314
2018
Q3 		$15K Buy
+188
New +$14.2K 0.01% 417

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Csenge Advisory Group's AZN Position: Q2 2026 in Review

Csenge Advisory Group increased its AstraZeneca (AZN) stake by 2.3% in Q2 2026, buying an estimated $11.8K and bringing the position to 2,853 shares worth $540K. The position accounts for 0.02% of the portfolio, ranked #442.

Csenge Advisory Group first reported a position in AZN in Q3 2018 and has held it in 19 quarters since. The position peaked at $795K in Q3 2021. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Csenge Advisory Group held 2,853 shares of AstraZeneca worth $540K as of Q2 2026.
  • Csenge Advisory Group bought 63 AstraZeneca shares in Q2 2026, an estimated $11.8K.
  • AstraZeneca made up 0.02% of Csenge Advisory Group's portfolio in Q2 2026, its #442 holding.
  • Csenge Advisory Group first reported a position in AstraZeneca in Q3 2018 and has held it in 19 quarters since.
  • Csenge Advisory Group's AstraZeneca position peaked at $795K in Q3 2021.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.